<DOC>
	<DOCNO>NCT01747109</DOCNO>
	<brief_summary>Oro-tracheal intubation intensive unit care ( ICU ) acute hypoxemic respiratory failure crash induction remain critical event . The aim study determine whether Nasal High Flow Therapy ( HFT ) Optiflow ® efficient face mask preoxygenation orotracheal intubation crash induction acute hypoxemic respiratory failure</brief_summary>
	<brief_title>Benefits Optiflow® Device Preoxygenation Before Intubation Acute Hypoxemic Respiratory Failure : The PREOXYFLOW Study</brief_title>
	<detailed_description>This study design follow : Patients randomize 2 group : '' PREOXYFLOW '' `` STANDARD FACE MASK '' . Patients randomize `` PREOXYFLOW '' group receive four minute preoxygenation period Nasal High Flow Therapy ( HFT ) ( 60 l/mn FIO2 = 1 ) orotracheal intubation laryngoscopy crash induction . Patients randomize `` STANDARD FACE MASK '' group receive four minute preoxygenation period standard face mask ( 15 l/mn ) orotracheal intubation laryngoscopy crash induction</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Adults older 18 year regardless gender Acute hypoxemic respiratory failure define : Respiratory rate &gt; 30/mn AND Hypoxemia SpO2 &lt; 90 % oxygen supply &gt; FiO2 0,5 AND PaO2/FiO2 &lt; 300 mmHg Contraindication orotracheal intubation Intubation without anesthetic delivery Intubation cardiac arrest Asphyxia immediate intubation need Nasopharyngeal obstacle contraindication use Optiflow device Patients document Cormack IV exposition inclusion Protected adult Pregnancy Lack consent Patient already enrol randomize study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Acute hypoxemic respiratory failure</keyword>
	<keyword>Preoxygenation</keyword>
	<keyword>Crash induction</keyword>
</DOC>